The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab

Takeuchi, Y; Nouso, K; Fujioka, S; Kariyama, K; Kobashi, H; Uematsu, S; Moriya, A; Hagihara, H; Takabatake, H; Nakamura, S; Yabushita, K; Kikuchi, T; Oyama, A; Adachi, T; Wada, N; Onishi, H; Shiraha, H; Takaki, A

Nouso, K (通讯作者)，Okayama City Hosp, Dept Gastroenterol, 3-20-1 Kitanagase Omotemachi,Kita Ku, Okayama, Okayama 7008557, Japan.

CANCER MEDICINE, 2023; 12 (17): 17559

Abstract

Background and Aims: The IMbrave 150 trial revealed the usefulness of atezolizumab plus bevacizumab therapy in patients with unresectable hepatocellul......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索